Localisation of N-acetylaspartate in oligodendrocytes/myelin

Brain Structure and Function

Volumn 220, Issue 2, 2015, Pages 899-917

  Nordengen, Kaja ^a   Heuser, Christoph ^a,b   Rinholm, Johanne Egge ^a,c   Matalon, Reuben ^d   Gundersen, Vidar ^a,e  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF BONN   (Germany)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d University of Texas Medical Branch School of Medicine   (United States)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Aspartate; Canavan disease; Cerebellum; Glutamate; Immunogold; leukodystrophy

Indexed keywords

ASPARTIC ACID; N-ACETYLASPARTATE;

ANALOGS AND DERIVATIVES; ANIMAL; BRAIN; BRAIN CHEMISTRY; CELL BODY; CHEMISTRY; GRAY MATTER; IMMUNOLOGY; MITOCHONDRION; MOUSE; MYELIN SHEATH; NERVE CELL; NERVE FIBER; OLIGODENDROGLIA; ULTRASTRUCTURE; WHITE MATTER; WISTAR RAT;

ANIMALS; ASPARTIC ACID; AXONS; BRAIN; BRAIN CHEMISTRY; CELL BODY; GRAY MATTER; MICE; MITOCHONDRIA; MYELIN SHEATH; NEURONS; OLIGODENDROGLIA; RATS, WISTAR; WHITE MATTER;

EID: 84890994383     PISSN: 18632653     EISSN: 18632661     Source Type: Journal    
DOI: 10.1007/s00429-013-0691-7     Document Type: Article

References (68)

1. Adachi M, Torii J, Schneck L, Volk BW (1972) Electron microscopic and enzyme histochemical studies of the cerebellum in spongy degeneration (van Bogaert and Bertrans type). Acta Neuropathol 20:22–31
2. Ariyannur PS, Moffett JR, Manickam P, Pattabiraman N, Arun P, Nitta A et al (2010) Methamphetamine-induced neuronal protein NAT8L is the NAA biosynthetic enzyme: implications for specialized acetyl coenzyme A metabolism in the CNS. Brain Res 1335:1–13
3. Arnold DL, de Stefano N, Matthews PM, Trapp BD (2001) N-acetylaspartate: usefulness as an indicator of viable neuronal tissue. Ann Neurol 50:823–825
4. Arun P, Moffett JR, Namboodiri AM (2009) Evidence for mitochondrial and cytoplasmic N-acetylaspartate synthesis in SH-SY5Y neuroblastoma cells. Neurochem Int 55:219–225
5. Baslow MH (2003) Brain N-acetylaspartate as a molecular water pump and its role in the etiology of Canavan disease: a mechanistic explanation. J Mol Neurosci 21:185–190
6. Bergersen LH, Storm-Mathisen J, Gundersen V (2008) Immunogold quantification of amino acids and proteins in complex subcellular compartments. Nat Protoc 3:144–152
7. Bhakoo KK, Pearce D (2000) In vitro expression of N-acetyl aspartate by oligodendrocytes: implications for proton magnetic resonance spectroscopy signal in vivo. J Neurochem 74:254–262
8. Boltshauser E, Schmitt B, Wevers RA, Engelke U, Burlina AB, Burlina AP (2004) Follow-up of a child with hypoacetylaspartia. Neuropediatrics 35:255–258
9. Burlina AP, Ferrari V, Divry P, Gradowska W, Jakobs C, Bennett MJ et al (1999) N-acetylaspartylglutamate in Canavan disease: an adverse effector? Eur J Pediatr 158:406–409
10. Burri R, Steffen C, Herschkowitz N (1991) N-acetyl-l-aspartate is a major source of acetyl groups for lipid synthesis during rat brain development. Dev Neurosci 13:403–411
11. Canavan MM (1931) Schilder’s encephalitis periaxialis diffusa—report or a case in a child aged sixteen and one-half months. Arch Neurol Psychiatry 25:299–308
12. Chakraborty G, Ledeen R (2003) Fatty acid synthesizing enzymes intrinsic to myelin. Brain Res Mol Brain Res 112:46–52
13. Chakraborty G, Mekala P, Yahya D, Wu G, Ledeen RW (2001) Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase. J Neurochem 78:736–745
14. De SA, Yu LM (2006) Preparation of organotypic hippocampal slice cultures: interface method. Nat Protoc 1:1439–1445
15. De Stefano N, Matthews PM, Antel JP, Preul M, Francis G, Arnold DL (1995) Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann Neurol 38:901–909
16. Einstein O, Friedman-Levi Y, Grigoriadis N, Ben-Hur T (2009) Transplanted neural precursors enhance host brain-derived myelin regeneration. J Neurosci 29:15694–15702
17. Gotoh M, Davies SE, Obrenovitch TP (1997) Brain tissue acidosis: effects on the extracellular concentration of N-acetylaspartate. J Neurochem 69:655–661
18. Gundersen V, Chaudhry FA, Bjaalie JG, Fonnum F, Ottersen OP, Storm-Mathisen J (1998) Synaptic vesicular localisation and exocytosis of l-aspartate in excitatory nerve terminals: a quantitative immunogold analysis in rat hippocampus. J Neurosci 18:6059–6070
19. Janson CG, McPhee SW, Francis J, Shera D, Assadi M, Freese A et al (2006) Natural history of Canavan disease revealed by proton magnetic resonance spectroscopy (1H-MRS) and diffusion-weighted MRI. Neuropediatrics 37:209–221
20. Kamada K, Takeuchi F, Houkin K, Kitagawa M, Kuriki S, Ogata A et al (2001) Reversible brain dysfunction in MELAS: MEG, and (1)H MRS analysis. J Neurol Neurosurg Psychiatry 70:675–678
21. Karadottir R, Cavelier P, Bergersen LH, Attwell D (2005) NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 438:1162–1166
22. Kaul R, Casanova J, Johnson AB, Tang P, Matalon R (1991) Purification, characterization, and localisation of aspartoacylase from bovine brain. J Neurochem 56:129–135
23. Kaul R, Gao GP, Balamurugan K, Matalon R (1993) Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease. Nat Genet 5:118–123
24. Klugmann M, Symes CW, Klaussner BK, Leichtlein CB, Serikawa T, Young D et al (2003) Identification and distribution of aspartoacylase in the postnatal rat brain. Neuroreport 14:1837–1840
25. Kolodziejczyk K, Hamilton NB, Wade A, Karadottir R, Attwell D (2009) The effect of N-acetyl-aspartyl-glutamate and N-acetyl-aspartate on white matter oligodendrocytes. Brain 132:1496–1508
26. Lee Y, Morrison BM, Li Y, Lengacher S, Farah MH, Hoffman PN et al (2012) Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487:443–448
27. Ledeen RW, Golly F, Haley JE (1992) Axon-myelin transfer of phospholipids and phospholipid precursors. Labeling of myelin phosphoinositides through axonal transport. Mol Neurobiol 6:179–190
28. Long PM, Moffett JR, Namboodiri AM, Viapiano MS, Lawler SE, Jaworski DM (2013) N-acetylaspartate (NAA) and N-acetylaspartylglutamate (NAAG) promote growth and inhibit differentiation of glioma stem-like cells. J Biol Chem 288:26188–26200
29. Madhavarao CN, Chinopoulos C, Chandrasekaran K, Namboodiri MA (2003) Characterization of the N-acetylaspartate biosynthetic enzyme from rat brain. J Neurochem 86:824–835
30. Madhavarao CN, Moffett JR, Moore RA, Viola RE, Namboodiri MA, Jacobowitz DM (2004) Immunohistochemical localisation of aspartoacylase in the rat central nervous system. J Comp Neurol 472:318–329
31. Madhavarao CN, Arun P, Moffett JR, Szucs S, Surendran S, Matalon R et al (2005) Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan’s disease. Proc Natl Acad Sci USA 102:5221–5226
32. Mahloudji M, Daneshbod K, Karjoo M (1970) Familial spongy degeneration of the brain. Arch Neurol 22:294–298
33. Martin E, Capone A, Schneider J, Hennig J, Thiel T (2001) Absence of N-acetylaspartate in the human brain: impact on neurospectroscopy? Ann Neurol 49:518–521
34. Matalon R, Rady PL, Platt KA, Skinner HB, Quast MJ, Campbell GA et al (2000) Knock-out mouse for Canavan disease: a model for gene transfer to the central nervous system. J Gene Med 2:165–175
35. Mathiisen TM, Lehre KP, Danbolt NC, Ottersen OP (2010) The perivascular astroglial sheath provides a complete covering of the brain microvessels: an electron microscopic 3D reconstruction. Glia 58:1094–1103
36. Mattan NS, Ghiani CA, Lloyd M, Matalon R, Bok D, Casaccia P et al (2010) Aspartoacylase deficiency affects early postnatal development of oligodendrocytes and myelination. Neurobiol Dis 40:432–443
37. Mehta V, Namboodiri MA (1995) N-acetylaspartate as an acetyl source in the nervous system. Brain Res Mol Brain Res 31:151–157
38. Mersmann N, Tkachev D, Jelinek R, Roth PT, Mobius W, Ruhwedel T et al (2011) Aspartoacylase-lacZ knockin mice: an engineered model of Canavan disease. PLoS One 6(5):e20336
39. Moffett JR, Namboodiri MA (1995) Differential distribution of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat forebrain. J Neurocytol 24:409–433
40. Moffett JR, Namboodiri AM (2006) Expression of N-acetylaspartate and N-acetylaspartylglutamate in the nervous system. Adv Exp Med Biol 576:7–26
41. Moffett JR, Namboodiri MA, Cangro CB, Neale JH (1991) Immunohistochemical localisation of N-acetylaspartate in rat brain. Neuroreport 2:131–134
42. Moffett JR, Namboodiri MA, Neale JH (1993) Enhanced carbodiimide fixation for immunohistochemistry: application to the comparative distributions of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat brain. J Histochem Cytochem 41:559–570
43. Moffett JR, Arun P, Ariyannur PS, Garbern JY, Jacobowitz DM, Namboodiri AM (2011) Extensive aspartoacylase expression in the rat central nervous system. Glia 59:1414–1434
44. Namboodiri AM, Moffett JR, Arun P, Mathew R, Namboodiri S, Potti A et al (2006) Defective myelin lipid synthesis as a pathogenic mechanism of Canavan disease. Adv Exp Med Biol 576:145–163
45. Narayana PA, Doyle TJ, Lai D, Wolinsky JS (1998) Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis. Ann Neurol 43:56–571
46. Ormel L, Stensrud MJ, Bergersen LH, Gundersen V (2012a) VGLUT1 is localized in astrocytic processes in several brain regions. Glia 60:229–238
47. Ormel L, Stensrud MJ, Chaudhry FA, Gundersen V (2012b) A distinct set of synaptic-like microvesicles in atroglial cells contain VGLUT3. Glia 60:1289–1300
48. Ottersen OP, Storm-Mathisen J (1984) Glutamate- and GABA-containing neurons in the mouse and rat brain, as demonstrated with a new immunocytochemical technique. J Comp Neurol 229:374–392
49. Patel TB, Clark JB (1979) Synthesis of N-acetyl-L-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport. Biochem J 184:539–546
50. Reichelt KL, Fonnum F (1969) Subcellular localisation of N-acetyl-aspartyl-glutamate, N-acetyl-glutamate and glutathione in brain. J Neurochem 16:1409–1416
51. Rinholm JE, Bergersen LH (2012) Neuroscience: the wrap that feeds neurons. Nature 487:435–436
52. Rinholm JE, Hamilton NB, Kessaris N, Richardson WD, Bergersen LH, Attwell D (2011) Regulation of oligodendrocyte development and myelination by glucose and lactate. J Neurosci 31:538–548
53. Schuff N, Ezekiel F, Gamst AC, Amend DL, Capizzano AA, Maudsley AA et al (2001) Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging. Magn Reson Med 45:899–907
54. Simmons ML, Frondoza CG, Coyle JT (1991) Immunocytochemical localisation of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 45:37–45
55. Soher BJ, van Zijl PC, Duyn JH, Barker PB (1996) Quantitative proton MR spectroscopic imaging of the human brain. Magn Reson Med 35:356–363
56. Sparrow N, Manetti ME, Bott M, Fabianac T, Petrilli A, Bates ML et al (2012) The actin-severing protein cofilin is downstream of neuregulin signaling and is essential for Schwann cell myelination. J Neurosci 32:5284–5297
57. Surendran S, Matalon KM, Tyring SK, Matalon R (2003) Molecular basis of Canavan’s disease: from human to mouse. J Child Neurol 18:604–610
58. Tallan HH, Moore S, Stein WH (1956) N-Acetyl-l-aspartic acid in brain. J Biol Chem 219:257–264
59. Tedeschi G, Bertolino A, Righini A, Campbell G, Raman R, Duyn JH et al (1995) Brain regional distribution pattern of metabolite signal intensities in young adults by proton magnetic resonance spectroscopic imaging. Neurology 45:1384–1391
60. Traka M, Wollmann RL, Cerda SR, Dugas J, Barres BA, Popko B (2008) Nur7 is a nonsense mutation in the mouse aspartoacylase gene that causes spongy degeneration of the CNS. J Neurosci 28:11537–11549
61. Truckenmiller ME, Namboodiri MA, Brownstein MJ, Neale JH (1985) N-Acetylation of l-aspartate in the nervous system: differential distribution of a specific enzyme. J Neurochem 45:1658–1662
62. Tsai G, Coyle JT (1995) N-acetylaspartate in neuropsychiatric disorders. Prog Neurobiol 46:531–540
63. Wang J, Matalon R, Bhatia G, Wu G, Li H, Liu T et al (2007) Bimodal occurrence of aspartoacylase in myelin and cytosol of brain. J Neurochem 101:448–457
64. Wang J, Leone P, Wu G, Francis JS, Li H, Jain MR et al (2009) Myelin lipid abnormalities in the aspartoacylase-deficient tremor rat. Neurochem Res 34:138–148
65. Wevers RA, Engelke U, Wendel U, de Jong JG, Gabreels FJ, Heerschap A (1995) Standardized method for high-resolution 1H-NMR of cerebrospinal fluid. Clin Chem 41:744–751
66. Wiame E, Tyteca D, Pierrot N, Collard F, Amyere M, Noel G et al (2010) Molecular identification of aspartate N-acetyltransferase and its mutation in hypoacetylaspartia. Biochem J 425:127–136
67. Wirt SE, Adler AS, Gebala V, Weimann JM, Schaffer BE, Saddic LA et al (2010) G1 arrest and differentiation can occur independently of Rb family function. J Cell Biol 191:809–825
68. Zeis T, Graumann U, Reynolds R, Schaeren-Wiemers N (2008) Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection. Brain 131:288–303